Coordinated regulation of Myc trans-activation targets by Polycomb and the Trithorax group protein Ash1 by Goodliffe, Julie M et al.
BioMed  Central
Page 1 of 16
(page number not for citation purposes)
BMC Molecular Biology
Open Access Research article
Coordinated regulation of Myc trans-activation targets by 
Polycomb and the Trithorax group protein Ash1
Julie M Goodliffe*1,2, Michael D Cole3 and Eric Wieschaus1
Address: 1Department of Molecular Biology, Princeton University, Princeton, NJ 08544, USA, 2Department of Biology, University of North 
Carolina Charlotte, 9201 University City Blvd., Charlotte, NC 28223, USA and 3Departments of Pharmacology and Genetics, HB 7936, Dartmouth 
Medical School, One Medical Center Drive, Lebanon, NH 03756, USA
Email: Julie M Goodliffe* - jmgoodli@uncc.edu; Michael D Cole - Michael.D.Cole@Dartmouth.EDU; Eric Wieschaus - efw@Princeton.EDU
* Corresponding author    
Abstract
Background: The Myc oncoprotein is a transcriptional regulator whose function is essential for
normal development. Myc is capable of binding to 10% of the mammalian genome, and it is unclear
how a developing embryo controls the DNA binding of its abundant Myc proteins in order to avoid
Myc's potential for inducing tumorigenesis.
Results: To identify chromatin binding proteins with a potential role in controlling Myc activity,
we established a genetic assay for dMyc activity in Drosophila. We conducted a genome-wide screen
using this assay, and identified the Trithorax Group protein Ash1 as a modifier of dMyc activity.
Ash1 is a histone methyltransferase known for its role in opposing repression by Polycomb. Using
RNAi in the embryo and Affymetrix microarrays, we show that ash1 RNAi causes the increased
expression of many genes, suggesting that it is directly or indirectly required for repression in the
embryo, in contrast to its known role in maintenance of activation. Many of these genes also
respond similarly upon depletion of Pc and pho transcripts, as determined by concurrent microarray
analysis of Pc and pho RNAi embryos, suggesting that the three are required for low levels of
expression of a common set of targets. Further, many of these overlapping targets are also
activated by Myc overexpression. We identify a second group of genes whose expression in the
embryo requires Ash1, consistent with its previously established role in maintenance of activation.
We find that this second group of Ash1 targets overlaps those activated by Myc and that ectopic
Myc overcomes their requirement for Ash1.
Conclusion: Genetic, genomic and chromatin immunoprecipitation data suggest a model in which
Pc, Ash1 and Pho are required to maintain a low level of expression of embryonic targets of
activation by Myc, and that this occurs, directly or indirectly, by a combination of disparate
chromatin modifications.
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Background
Cancer can arise in many ways, one of the most potent
being deregulation of the myc proto-oncogene. Myc is a
transcription factor, and its C-terminal domain is required
for dimerization with its partner Max and its subsequent
binding to DNA. It also possesses an N-terminal trans-
activation domain that is required for both Myc's biologi-
cal activities of transcriptional activation and repression.
Activation by Myc involves binding to the nuclear protein
TRRAP, which recruits histone acetyltransferase com-
plexes to Myc activation targets. Subsets of target genes
include those that mediate cell cycle progression, cell
growth, genomic instability, angiogenesis, and inhibit dif-
ferentiation [1-3]. Myc also acts as a repressor of a differ-
ent set of targets, in addition to interfering with the
function of activators such as Miz1 [4,5]. Myc binding to
DNA is dependent on chromatin context, such that Myc
sites having certain chromatin modifications are almost
always bound, and Myc sites lacking those certain modifi-
cations are rarely bound by Myc [6].
Experiments in mammalian systems have answered many
questions regarding Myc biology, though their limitations
in broad based discovery led us to investigate Myc biology
in Drosophila. The dMyc protein is highly similar to c-Myc
in the residues required for DNA binding, and the gene
has a similar exon and intron structure [7,8]. dMyc can
functionally replace c-Myc in transformation assays with
activated Ras and in rescue experiments with mouse cells
null for c-myc [8,9]. In Drosophila, dMyc regulates RNA
Pol I production of ribosomal RNAs, is required for oog-
enesis and larval growth, and overexpression of dmyc in
clones of the Drosophila imaginal disc confers a growth
advantage to cells having greater amounts of dmyc expres-
sion than their neighbors [10-14].
In a transgenic mouse model using induction of Myc in
hepatocytes, the ability of Myc to induce proliferation and
tumorigenesis was shown to vary greatly depending on
the age of the mouse at the time Myc was induced, sug-
gesting that the differentiation states of cells can mediate
the response to Myc [15]. In Drosophila, differentiated or
undifferentiated cell states are maintained by the Poly-
comb Group (PcG) and Trithorax Group (TrxG) of pro-
teins, which are thought to bind to repressed or activated
loci, and thus to stabilize patterns of gene expression
[16,17]. We reported previously that repression by Myc in
Drosophila requires Polycomb, a chromatin-binding tran-
scriptional repressor [18]. Previously characterized phe-
notypes manifested in PcG mutants reflect a loss of
repression of homeotic genes, and the members of the
PcG group were additionally defined by their ability to
enhance each other's dominant phenotypes [19,20] (and
references within). Conversely, mutant phenotypes of
members of the TrxG reflect a loss of activation of home-
otic genes, and these mutations behave as suppressors of
mutations in Pc. Many of the members of the PcG of pro-
teins have been found in two separate protein complexes,
PRC1 and PRC2, neither of which bind to DNA alone.
PRC1 includes Pc, Ph, Psc and dRing1; PRC2 includes Esc;
a histone methyltransferase, E(z); and Su(z)12. PcG pro-
teins bind to hundreds of sites in the genomes of mam-
mals and Drosophila [21-25], and repression of homeotic
genes mediated by PcG proteins is experimentally linked
to cis regulatory elements known as PREs (Polycomb
Response Elements, reviewed in [26,27]). The PcG pro-
teins Pho and dSfmbt bind to sites within PREs, recruiting
PRC2, followed by recruitment of PRC1 [28-32]. TrxG
proteins bind to over 100 sites on polytene chromosomes
and can be found in nucleosome remodeling complexes
such as the BAP complex (Brahma Associated Protein
complex: Brahma, Moira, Osa and Snr1). Trx and Ash1
(absent, small or homeotic discs 1) are SET domain his-
tone methyltransferases (reviewed in [33]).
Repression by Myc requires Pc for many targets, which
includes the dmyc locus itself [18]. In the present study, we
describe a novel genetic assay that we use to find addi-
tional Drosophila gene products involved in repression of
the dmyc gene. Using this assay, we screened the Drosophila
genome for modifiers of dmyc expression. We then used
RNAi to deplete levels of our genetic modifiers, Ash1 and
Pho, in the embryo and used Affymetrix microarrays to
analyze gene expression changes in these embryos with or
without ectopic Myc. Our genetic and genomic data allow
us to describe the role of Pho and Ash1 in Myc-mediated
repression and in control of Myc trans-activation targets in
the embryo. These data provide the first evidence for a
functional link between canonical Pc and Trx Group pro-
teins.
Results
Pho and Psc are involved in repression of dmyc
Pc binds to methylated histone H3 at lysine 27 (H3K27),
mediating repression of many genetic loci by Myc [18]. In
an investigation of other PcG gene products potentially
involved in this repression by Myc and Pc, we chose three
candidates to test: Posterior sex combs (Psc), which is in a
core repressive complex with Pc [34]; E(z), which is a his-
tone methyltransferase that methylates histone H3 lysine
27 and recruits Pc repression [35-37]; and Pho, which is
one of two DNA-binding proteins of the group and
recruits E(z) [28,30-32]. Our strategy for testing Psc, E(z)
and Pho involved a genetic test for modification of expres-
sion at the dmyc locus. Each of two different P element
insertions in the dmyc locus, dmycBG02383 and dmycBG00605,
provides two reporters for dmyc expression: a promoter-
less yeast Gal4 gene that is expressed by the upstream dmyc
promoter, and a Drosophila  eye color mini-white  gene
whose expression is influenced by the regulation of the
locus (Figure 1A) [38,39].BMC Molecular Biology 2007, 8:40 http://www.biomedcentral.com/1471-2199/8/40
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We first determined whether these reporters were sensitive
to the regulation of the dmyc gene, using the phenomenon
of dmyc autorepression. In this assay, ectopic dmyc leads to
a reduction in the expression from the endogenous locus
[18]. We obtained high levels of ectopic Myc in embryos
with the dmycBG02383 allele (see Methods for genotypes
and crosses). We collected RNA from dmycBG02383 embryos
with or without ectopic dmyc and used RT-PCR to amplify
transcripts from the Gal4 and mini-white reporters, the first
exon of dmyc (which amplifies only the endogenous tran-
script and not the exogenous transcript), and a loading
control, dRas. Expression of endogenous dmyc in embryos
with the P-element insertion is normal, and Northern
blotting indicates that the mature transcript size is the
same as in wild type (Figure 1B and data not shown).
Endogenous  dmyc  expression detected by RT-PCR in
embryos with ectopic Myc was close to zero (Figure 1B),
indicating that autorepression is intact in dmycBG02383
embryos. Phosphorimaging data revealed a reproducible
reduction in both mini-white  and  Gal4  expression in
embryos with ectopic dmyc (Figure 1B). The effect was
small but striking, given that the embryos contain sources
of mini-white and Gal4 in addition to those from the inser-
tion in dmyc (i.e. the two transgenes that we used to pro-
vide ectopic dmyc, UAS dmyc and Gal4, both have mini-
white associated with them). These results provided the
molecular validation for our genetic strategy, linking dmyc
regulation to the expression of the reporters within the
locus.
We reasoned that reducing the dosage of a gene involved
in dmyc repression might elevate the mini-white expression
above that normally observed in dmycBG00605  and
dmycBG02383 flies. Therefore, we generated flies with muta-
tions in candidate dmyc  repressors combined with the
dmyc reporters and examined levels of mini-white expres-
sion (see Methods for genetic crosses and scoring proce-
dures). Heterozygosity (i.e. one mutant chromosome and
one wild type chromosome) for a Pc mutation did not
increase mini-white  levels of dmycBG02383 males, but did
affect mini-white levels of dmycBG00605 (16% dark Pc3 males
versus 0 dark non-mutant control male siblings, Table 1).
Heterozygosity for a Psc mutation affected both insertions
in  dmyc, increasing the mini-white  levels compared to
those of the non-mutant siblings in both cases (60% dark
for dmycBG02383, 44% dark for dmycBG00605, 18% dark for
the non-mutant controls, Figure 2A and Table 1). Males
heterozygous for either of two different loss-of-function
alleles of E(z), E(z)5 and E(z)61, did not increase mini-
white levels of either insertion in dmyc; E(z) males and
non-mutant male siblings had indistinguishable mini-
white intensities. Males heterozygous for a hypomorphic
mutation in pho, pho1, had greater numbers of males with
dark eyes than their non-mutant siblings, with 57% of
pho1 heterozygotes having dark eyes compared to 5% of
the non-mutant flies having dark eyes (Figure 2B and
Table 1). Therefore, we considered dmycBG00605 to be the
more sensitive reporter for dmyc  expression because it
revealed regulation by Pc. Psc and pho mutations affected
both insertions, suggesting their involvement in Pc/Myc
repression. However, neither insertion was affected by
E(z) mutations, suggesting that E(z) may not be involved
in repression by Myc or that mutations in E(z) are not
haploinsufficient with respect to Myc activity.
Pho participates with Pc in repression of Myc targets
The Pho protein is thought to recruit Pc to PREs [30-32]
and in that way facilitates Pc's repressive activity. Require-
A P element insertion in the dmyc locus is a reporter for  dmyc activity Figure 1
A P element insertion in the dmyc locus is a reporter 
for dmyc activity. (A) A diagram indicating the exons 
(green rectangles) and introns (thick blue line) of the dmyc 
gene on the X chromosome. A pGT1 insertion in the second 
intron (dmycBG02383, top) inserts the Gal4 (blue rectangle) and 
mini-white (red rectangle) reporters. A second insertion 
upstream of the dmyc transcription site is also shown 
(dmycBG00605, bottom) (B) Gal4 and mini-white reporters 
exhibit dmyc autorepression. RT-PCR amplification products 
are shown from embryos with dmycBG02383 having Gal4 or 
Gal4; UAS-dmyc transgenes, and therefore wild type for Myc 
(wt) or producing ectopic Myc (Myc++), respectively. The 
numbers under each band indicate the relative band intensi-
ties between pairs as indicated by phosphorimaging. (C) 
Scheme for genetic screen for modifiers of dmyc activity. 
Females homozygous for dmycBG02383 on the X Chromosome 
were crossed to males of the Second and Third Chromo-
some deficiency "kits" (Bloomington). Fly heads are depicted 
in profile, cartooning the changes in eye color expected 
when a fly has both dmycBG02383 and either a mutation in a 
dmyc activator (upper right) or a mutation in a dmyc repres-
sor (lower right).BMC Molecular Biology 2007, 8:40 http://www.biomedcentral.com/1471-2199/8/40
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ments for Pho activity might therefore be expected to par-
allel those for Pc with respect to repression by Myc, as
suggested by our mini-white  assay described above. To
examine this possibility, we injected embryos with dsRNA
directed at pho, reducing transcript levels 6-fold (Figure
3A). We also induced RNAi for pho  in embryos with
ectopic Myc to examine the role that Pho has in Myc func-
tion. In addition to pho RNAi, we repeated the Pc RNAi
experiment (4-fold reduction in Pc levels) for comparison
using the Drosophila Genome 2.0 Affymetrix arrays (Fig-
ure 3A). As described previously [18], we also injected
embryos with buffer for our controls, injected 200
embryos for each array hybridization, and duplicated the
entire experiment, for a total of 400 injected embryos ana-
lyzed per genetic condition. We injected pre-cellulariza-
tion embryos, and allowed them to age for 20 hours at
18°C before isolating RNA. This technique of using RNAi
rather than known mutations in pho and Pc for our micro-
array analysis has several advantages. First, variability
between genetic backgrounds is eliminated, since geneti-
cally identical mothers provided the embryos for our
experiments from array to array, no matter what gene we
depleted by RNAi or whether the fathers provided ectopic
Myc or not (Figure 4). Second, transgene expression is
constant from chip to chip because we used the identical
Gal4 source and UAS-dmyc for all experiments, without
concern for the logistics of combining three different
genetic situations in one set of embryos. Third, because we
reduced both maternal and zygotic transcripts by RNAi,
our experiments did not require that we generate germ
line clones to eliminate the maternal contribution of tran-
scripts.
Our experiments reveal 329 target genes that appear to be
repressed by Pho in normal embryos, since their levels
increase following pho RNAi (see Methods for list genera-
tion). A larger number of Pc repression targets were iden-
tified following Pc RNAi (625, Table 2), and consistent
with the view that Pc and Pho work together, the two
groups of targets show substantial overlap; 146 of the 329
pho targets are also Pc targets (Figure 3D). That the
remaining 183 Pho targets do not appear to overlap Pc tar-
Psc,pho and ash1 behave as genetic repressors of the dmyc  locus Figure 2
Psc,pho and ash1 behave as genetic repressors of the 
dmyc locus. (A) Male siblings are shown, both hemizygous 
for dmycBG02383, and either heterozygous for Psc1 (left), or the 
balancer chromosome (CyO). (B) Male siblings are shown, 
both hemizygous for dmycBG02383, and either heterozygous for 
pho1 (left), or the balancer chromosome (In(4)ciD). (C) Male 
siblings are shown, same as in A and B, though heterozygous 
for either Df(3L)XS533, a Df that includes ash1 (left), or the 
balancer chromosome (TM6B).
Table 1: Deficiencies and mutants that behave as genetic 
repressors of dmyc
Deficiency/
mutant
Cytology P value
Df(2R)vg135 47F04-048A;049A-B, 49A-B;049D-E 1.50E-21
Df(3L)Aprt-32 62B01;062E03 2.73E-06
Df(3L)BSC13 66B12-C01;066D02-04 9.91E-04
Df(3L)lxd6 67E05-07;068C02-04 2.32E-07
Df(3L)BSC10 69D04-05;069F05-07 4.72E-206
Df(3L)fz-CAL5 70C02-06;070E01 2.34E-33
Df(3L)kto2 76B01-02;076D05 1.84E-52
Df(3L)XS533 76B04;077B 1.60E-21
Df(3R)p712 84D04-06;085B06, 025D;085B06 5.03E-10
Df(3R)M-Kx1 86C01;087B01-05 1.93E-05
Df(3R)T-32 86E02-04;087C06-07 4.02E-95
ash1 RE418 76B8-9 4.09E-58
Pc3* 78C6-7 5.65E-10
Psc1 49E6 8.51E-57
pho1 102D6 2.87E-34
E(z) 67E5 no change
ash2 96A13 no change
P values were computed using a chi-square test statistic. The asterisk 
refers to the combination of Pc3 and dmycBG00605, rather than 
dmycBG02383.BMC Molecular Biology 2007, 8:40 http://www.biomedcentral.com/1471-2199/8/40
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Pho behaves similarly to and differently from Pc with respect to Myc activity Figure 3
Pho behaves similarly to and differently from Pc with respect to Myc activity. For all scatter-plot graphs, the diago-
nal blue lines indicate zero change and 2-fold changes in either direction. Our thresholds for labeling genes as increasing or 
decreasing are not based on fold changes (see Methods), and therefore the locations of the colored dots may or may not cor-
respond to a 2-fold change in expression. (A) Results of genetic manipulations. The log2 ratios of normalized intensities are 
graphed for each manipulated gene in each manipulated embryo. The left-most set of bars are from embryos expressing 
ectopic dmyc, and each bar shows the change in Pc, pho, ash1 and dmyc levels, respectively, in those embryos compared to 
embryos with just Gal4 (log2 (intensity Gal4 dmyc/intensity Gal4)). The next set of bars shows the changes in Pc, pho, ash1 and 
dmyc in embryos with ash1 RNAi, and so on. The genetic manipulation is indicated above each set of 4 bars. (B) Expression lev-
els of 8865 genes are plotted by their basal levels along the X axis and their levels upon expression of ectopic Myc along the Y 
axis. Genes repressed by Myc are shown in red, n = 57. (C) Pc and Pho are required for Myc repression of half its targets. 
Expression changes, represented as log2 of ratios of expression over basal, of 55 Myc repressed transcripts are shown with 
changes with ectopic Myc (blue bar) next to their expression changes with ectopic Myc and Pc RNAi combined (red bar, top), 
or ectopic Myc and pho RNAi combined (red bar, bottom). The same 55 genes are graphed in the same order in both the 
upper and lower panels. (D) Expression levels of 8865 genes are plotted by their basal levels along the X axis and their levels 
upon pho RNAi along the Y axis. Red dots indicate genes whose levels rise with pho RNAi alone, blue dots indicate genes 
whose levels rise with Pc RNAi alone, and purple dots indicate genes whose levels rise with each of Pc or pho RNAi. (E) Expres-
sion levels of 8865 genes as in D, showing changes with ectopic Myc. Blue dots indicate genes whose levels rise with ectopic 
Myc. Red dots indicate genes whose levels rise with pho RNAi, purple indicates genes whose levels rise in each of ectopic Myc 
and pho RNAi.BMC Molecular Biology 2007, 8:40 http://www.biomedcentral.com/1471-2199/8/40
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gets may reflect the limitations of the threshold tech-
niques used to identify targets in our experiments. It may
also reflect differences of specific targets in their sensitivity
to reductions in Pc and Pho (see Discussion). The shared
regulatory roles of Pc and Pho extend beyond normal
development to those 57 genes that are repressed in
embryos following ectopic Myc accumulation (Figure 3B).
26 of these are no longer repressed to the same degree in
the absence of Pho, and 25 are no longer repressed to the
same degree in the absence of Pc (in the combined condi-
tion of ectopic Myc and RNAi of Pc or pho, Figure 3C and
Table 3). These genes that fail to be repressed in the
absence of Pc or Pho do not overlap completely. 15 are
affected by Pc and Pho similarly, 10 are affected by Pc and
not Pho, and 10 are affected by Pho and not Pc. We con-
clude that normal levels Pho and Pc are required for Myc's
repressive activity, though not necessarily at the same
time.
We examined the possibility that Pc mediates its repres-
sive effects upon dMyc targets by utilizing previously char-
acterized Polycomb Responsive Elements (= PREs). The
location of both Pc and Myc repressed genes, however,
provides no evidence of close proximity to each other
(Figure 5A). Because we were able to map target genes to
chromosomes using Genespring with Affymetrix Dro-
sophila Genome 1 data and not Genome 2.0, we used our
previous set of Pc repressed genes to compare to the loca-
tions of likely PREs [18]. We compared the genomic loca-
Table 3: Gene list matrix
Myc 
activated
Myc 
repressed
up 
ash1-
down 
ash1-
up 
pho-
down 
pho-
up 
Pc-
down 
Pc-
up 
Myc 
ash1
down 
Myc 
ash1-
up Myc 
pho-
down 
Myc pho
up Myc 
Pc-
down 
Myc Pc-
Myc activated 680 0 142 70 260 4 210 9 504 4 373 0 146 21
Myc repressed 0 57 1 3 0 11 10 6 0 47 0 31 0 32
up ash1- 142 1 239 0 139 4 130 0 142 6 156 4 49 9
down ash1- 70 3 0 159 35 4 26 8 53 9 22 7 11 20
up pho- 260 0 139 35 329 0 146 6 238 1 207 0 61 16
down pho- 4 11 4 4 0 69 14 8 7 19 7 14 1 21
up Pc- 210 10 130 26 146 14 625 0 227 17 209 8 161 12
down Pc- 9 6 0868 0 7 6 1 1 2 3 7 0 4 7
up Myc ash1- 504 0 142 53 238 7 227 1 675 0 401 0 198 17
down Myc ash1- 4 47 6 9 1 19 17 12 0 120 1 57 0 63
up Myc pho- 373 0 156 22 207 7 209 3 401 1 486 0 149 18
down Myc pho- 0 31 4 7 0 14 8 7 0 57 0 82 0 55
up Myc Pc- 146 0 49 11 61 1 161 0 198 0 149 0 462 0
down Myc Pc- 21 32 9 20 16 21 12 47 17 63 18 55 0 291
Genes in each list are shown for their membership in every other list.
Biological replicates of microarray hybidizations are highly  comparable Figure 4
Biological replicates of microarray hybidizations are highly 
comparable. Normalized intensities for all 18660 transcripts 
on the Affymetrix Drosophila Genome 2.0 array are graphed 
for one replicate on the X axis, and the second replicate is 
the Y axis. Both sets were normalized to the average signal 
for the chip, and to control intensities.
Table 2: Numbers of genes responding to ectopic Myc, ash1 RNAi 
(ash1-), (pho-), Pc RNAi (Pc-), and Myc combined with each
List Number of genes
Myc activated 680
Myc repressed 57
up ash1- 239
down ash1- 159
up pho- 329
down pho- 69
up Pc- 625
down Pc- 76
up Myc ash1- 675
down Myc ash1- 120
up Myc pho- 486
down Myc pho- 82
up Myc Pc- 462
down Myc Pc- 291
See Methods for list generation.BMC Molecular Biology 2007, 8:40 http://www.biomedcentral.com/1471-2199/8/40
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tions of 214 Pc repressed genes to the genomic locations
of experimentally determined Pc binding sites [24,25,40].
13 of the 214 Pc responsive genes in our data overlap Pc
binding sites, and 30 of the remaining 214 are within two
cytological number divisions of Pc binding sites for one
set of published data (i.e. gene at 61C7 and Pc binding at
61C9 or closer) [40]. Compared to a different set of pub-
lished Pc binding sites, 8 of 214 Pc responsive genes of our
set are within Pc binding sites [25]. The overlap is small,
though interestingly, the overlap of the two previously
published Pc binding sites with each other is also small:
just 1 of 43 genes with Pc binding sites in our set is com-
mon to the data sets of both Schwartz et. al. and Tolhuis
et. al. A third set of mapped Pc binding sites describes
many fewer Pc binding sites, and two of those overlap our
Pc responsive genes [24]; these two are also described as
being Pc binding sites by Swartz et. al. (Figure 5B). We
conclude that Pc binding is dynamic, with no absolute set
of Pc binding sites. Each set of data is a snapshot of the
current and changing position of Pc, and our gene expres-
sion data is consistent with the dynamic and possibly sto-
chastic nature of Pc binding to the genome.
Our previous experiments indicated that many of the
genes activated by Myc are normally repressed by Pc [18].
We were curious whether Pho repression overlapped Myc
activation to the same extent. The levels of 680 transcripts
increase with ectopic Myc. Of the 329 genes whose levels
increase with pho RNAi, 260 are among the 680 Myc acti-
vation targets (Table 3, Figure 3E). Therefore, a substantial
role for Pho in normal embryos is to repress genes that can
be activated by ectopic Myc.
We examined our embryonic Myc activation targets for
the presence of transcription factor binding sites. Using P-
Match to search our sequences for known transcription
factor binding sites within the Transfac database [41], we
found 0 of 680 Myc induced targets that have canonical
vertebrate Myc-binding E-boxes from the 0 position
through the first exon. E-boxes in Drosophila are most
likely to be found from -50 to +50, with the majority
between 0 and 50 [42]. The lack of E-boxes may simply
reflect the nature of our embryonic Myc targets, which
exclude those that are maternally deposited because those
transcripts are present in both our experimental and con-
trol embryos. It is possible that our zygotic Myc targets are
part of a different set that are induced by non-canonical
binding sites. Among Drosophila genes bound by dam-
Myc, 95% of the sites identified at those loci were not the
canonical CACGTG [43]. We did find, however, many
Myc activated transcripts with vertebrate YY1 sites, which
is the homolog of Drosophila Pho. The mammalian tran-
scription factor YY1 is able to bind to PREs and recruit Pc
repression in Drosophila [44], and 32 of 680 Myc acti-
vated genes have YY1 sites. To determine the significance
of this number, we used P-Match to search the sequences
of 50 random Drosophila genes, and 3 of those have YY1
sites as well. Therefore, we considered the appearance of
32 YY1 sites in our set of 680 Myc activated genes to be
similar to what is found randomly.
Mutations in ash1 cause increased expression of the dmyc 
gene
To search for other components that might mediate a
Pho/Myc/Pc interaction, we conducted an unbiased
genetic screen of large deletions on the Second and Third
Chromosomes (comprising 80% of the Drosophila
genome). Because dmycBG02383 flies have a darker eye color
that is easier to score than dmycBG00605, we used
Pc and Myc responsive genes are not clustered near genomic  Pc binding sites Figure 5
Pc and Myc responsive genes are not clustered near 
genomic Pc binding sites. (A) Chromosomes of the Dro-
sophila genome are shown, with a vertical blue bar above or 
below (plus or minus strand, respectively) each chromosome 
to indicate Myc repressed genes. Red vertical bars show the 
locations of Pc repressed genes, and lilac vertical bars show 
genes repressed by both. (B) 110 Pc repressed genes on the 
2nd and X Chromosomes are graphed for their location over-
lapping or near a Pc binding site. According to data published 
by three different groups, a gene overlapping a Pc binding site 
is given a score of 1, a gene near a Pc binding site is given a 
score of 0.5, and a gene not near a Pc binding site is given a 
score of 0. Bars are labeled blue, B. Tolhuis et al., Nat Genet 
(Apr 20, 2006); magenta, Y. B. Schwartz et al., Nat Genet 38, 
700 (Jun, 2006); green, N. Negre et al., PLoS Biol 4, e170 (Apr 
20, 2006). We did not plot genes on the 3rd Chromosome 
because the data set from Tolhuis et. al. does not include it.BMC Molecular Biology 2007, 8:40 http://www.biomedcentral.com/1471-2199/8/40
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dmycBG02383 in our screen. Out of a total of 154 Deficiency
mutants (Dfs), 16 scored as decreasing mini-white levels of
dmycBG02383 and 15 scored as increasing mini-white expres-
sion (screen scheme is shown in Figure 1C). Among the
latter Dfs, we were particularly interested in the overlap-
ping region of Df(3L)kt02 and Df(3L)XS533 because it
includes  ash1, a histone methyltransferase [45,46]. We
tested specific ash1 mutants for their ability to recapitulate
the phenotype seen in the two overlapping deficiencies
and found that 69% of ash1RE418 mutant males had darker
mini-white compared to 8% of their non-mutant siblings
(Figure 2C and Table 1). To be sure that the mutations
that scored as affecting the insertion in dmyc were indeed
affecting dmyc expression and not mini-white in general,
we conducted independent control crosses of a mini-white
P element insertion (pGT1) on the X chromosome,
BG00979, to every mutation and deficiency that scored
positive in our assay. We found that 2 deficiencies affected
this non-dmyc mini-white insertion and ruled them out.
The rest, including Pc, Psc,pho  and ash1, did not affect
mini-white  levels of the non-dmyc  associated insertion
(data not shown). Therefore, our genetic assay provided a
DNA binding protein (Pho) and a histone methyltrans-
ferase (Ash1) as potential mediators of Myc-Pc activity.
Depletion of Ash1 and Pc in the embryo results in similar 
gene expression changes
Although Ash1 appears to be involved in repression of
dmyc with Pho and Pc in our mini-white assay, it is known
as a Trithorax Group gene. Ash1 mutant phenotypes and
genetic interactions suggest that, at least with respect to
homeotic loci, it works in opposition to the activity of the
Pc Group [47-51]. To examine the full range of functions
for Ash1, beyond regulation of the homeotic selector
genes, we conducted microarray experiments comparing
gene expression changes between embryos with wild type
and reduced levels of ash1. We injected embryos with
dsRNA directed at ash1, reducing transcript levels 2-fold
(Figure 3A). We also induced RNAi for ash1 in embryos
with ectopic Myc to examine the role that Ash1 has in Myc
function. The experiments were conducted the same way
as described above for pho RNAi.
We first characterized Ash1's potential repressive activity
in the embryo, determining whether ash1  RNAi causes
increased expression of certain transcripts and whether
those targets overlap Myc or Pc activities. We found that
levels of 239 genes increase with ash1 RNAi, suggesting
that Ash1 behaves directly or indirectly as a repressor in
the embryo (Table 2, Figure 6A). 142 of these 239 genes
are activated by Myc (Figure 6B, purple). The overlap par-
allels our previous findings with Pc and Pho, and suggests
that, in the embryo, a significant role of Ash1, Pho and Pc
is to control the expression of targets that are activated by
ectopic Myc. In addition, we found that 130 of the 239
Ash1 repression targets are also Pc repression targets (Fig-
ure 6C, purple). This overlap is at least as large as that
observed for Pho and Pc and provides the first molecular
link between Pc and a TrxG protein in repression. This
link may be the result of either direct or indirect activities
of Pc and Ash1. The overlap of Pc/Pho and Ash1 repres-
sion targets is not limited to genes activated by Myc. 66 of
the 97 non-Myc targets repressed by Ash1 are also
repressed by Pc or Pho.
The genetic assay that revealed that Ash1 is involved in
Myc biology was one assessing repression of the dmyc
locus. Therefore, we examined the 57 Myc repressed genes
for any requirement of Ash1 in that repression. In an
embryo with ectopic Myc and ash1  RNAi, 47 of those
genes remain repressed (Table 3) suggesting that Ash1 is
required for Myc repression at only a small fraction of its
targets (i. e., 10/57 = 18%). In contrast, 25 of the same 57
Myc repressed targets were no longer repressed to the
same degree when Pc levels were reduced. This effect is
more pronounced than that of Ash1 and may indicate a
more direct role for Pc in Myc repression. These numbers
do not represent absolute repression by Ash1 and Pc,
however, given that the RNAi depletion of these tran-
scripts was not complete. In fact, Pc levels were reduced 2
fold more than ash1 transcripts, as measured by microar-
ray.
Ectopic Myc replaces Ash1 in activation
Consistent with Ash1's known role in gene activation, lev-
els of 159 genes decrease in response to ash1 RNAi (Figure
6A, Table 2), an effect that is superficially similar to the
positive role of Ash1 in regulating homeotic gene activity.
70 of these 159 genes are also Myc activation targets. In
contrast, only 9 of 76 genes whose levels decrease with Pc
RNAi are also Myc activated (Table 3). Similarly, just 4 of
69 genes whose levels decrease with pho RNAi are also Myc
activated (Table 3), suggesting that Pc and Pho are
unlikely to be functioning similarly to Ash1 with respect
to gene activation. Given this overlap between activation
targets of Myc and Ash1, we hypothesized that ectopic
Myc might rescue the loss of activation that occurs with
ash1 RNAi. If this were the case, we would expect that
genes whose levels decrease with ash1 RNAi alone would
in fact increase with ash1 RNAi and ectopic Myc. Consist-
ent with this notion, we found that levels of 81 of these
159 genes are significantly elevated above basal levels in
embryos with both ectopic Myc and ash1  RNAi, and
expression of 68 genes is at basal levels (Figure 6D). Only
10 of the 159 genes whose levels are reduced with ash1
RNAi remain reduced in the presence of ectopic Myc.
Therefore, a large majority of genes that are activated by
Ash1 are not only Myc activated, but Myc can replace Ash1
in their activation. These results also suggest that, whileBMC Molecular Biology 2007, 8:40 http://www.biomedcentral.com/1471-2199/8/40
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Ash1 protein's activities overlap those of Pc and Myc Figure 6
Ash1 protein's activities overlap those of Pc and Myc. (A) Expression levels of 8865 genes are plotted by their basal lev-
els along the X axis and their levels upon ash1 RNAi along the Y axis. Red dots indicate genes whose levels rise with ash1 
RNAi, and blue dots indicate genes whose levels decrease with ash1 RNAi. (B) Expression levels of 8865 genes are plotted by 
their response to ectopic Myc. Basal levels are along the X axis, and levels with ectopic Myc are along the Y axis. Genes in red 
are elevated by ash1 RNAi alone. Genes in blue are elevated by ectopic Myc alone, and genes in purple are elevated by both 
conditions individually. (C) Expression levels of 8865 genes are plotted by their response to Pc RNAi, plotted by their basal lev-
els along the X axis and their levels with Pc RNAi along the Y axis. Genes in red are elevated by ash1 RNAi alone, genes in blue 
are elevated by Pc RNAi alone, and genes in purple are elevated by both conditions individually. (D) Ectopic Myc replaces Ash1 
in gene activation. Changes in expression of 160 genes are shown, log2 of ratios of expression over basal, for transcripts whose 
levels drop with ash1 RNAi (blue bars). For each of the 169 genes, the change in expression in embryos with ash1 RNAi com-
bined with ectopic Myc is also shown (red bars, next to blue bar for each gene).BMC Molecular Biology 2007, 8:40 http://www.biomedcentral.com/1471-2199/8/40
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Ash1 is important in the activation of these genes, they do
not require wild type levels of Ash1 to be activated by Myc.
Ash1 is required for Myc activation
We were curious about the inverse, whether Ash1 is
required for activation by Myc. Levels of 680 genes
increase upon activation of ectopic Myc. In embryos with
both ectopic Myc and ash1 RNAi, levels of 76 of these
genes fail to increase at the same level (Figure 7A). None
of these 76 genes is also regulated by Ash1 alone, suggest-
ing that Ash1's regulation of these genes is limited to acti-
vation by Myc. Upon closer examination of the 76 genes,
we found a cluster of 60 that are regulated by Pc and Pho
(Figure 7B, generated by K-means clustering of Myc activa-
tion targets). The regulation of these genes by Pc and Pho
is negative, in that the targets have elevated expression
with Pc or Pho RNAi (Figure 7B). Therefore, many of these
targets are normally repressed by Pc/Pho. Among the
named genes in this group, several encode structural con-
stituents, such as Ccp84Ac (larval cuticle), Dhc62B
(Dynein Heavy chain 62B) and Actin 88F, and some are
involved in metabolism, such as Glycogenin and Lipase1.
One possible explanation for the regulation of these Myc
targets is that the role of Ash1 is to oppose Pc/Pho repres-
sion, allowing Myc activation. In fact, Ash1 opposes Pc
repression at homeotic loci [47]. Therefore, our data sug-
gest that Ash1 also opposes Pc repression at loci activated
by Myc (Figure 7C).
Myc targets exhibit disparate histone modifications
In many of our experiments, Pc, Pho and Ash1 proteins
facilitate Myc's activity as a repressor, but also appear to
oppose its activity as an activator. In an attempt to under-
stand how the same proteins cooperate with Myc to
repress one set of targets and conversely work to repress a
different set of Myc activation targets, we have to consider
a major difference between Myc's targets of activation and
repression: before Myc acts upon them, repression targets
are necessarily being expressed while activation targets are
largely unexpressed (Figure 8A).
Myc's embryonic targets of activation, prior to induction
of ectopic Myc, are expressed at low levels and our data
show that Pc, Pho and Ash1 are required to maintain that
pattern of expression. To examine Myc targets for hall-
marks of both Ash1 and Pc activity, we used chromatin
immunoprecipitation to examine the methylation of his-
tone tails in wild type embryos. Because Ash1 methylates
H3K4, a chromatin modification that correlates with
mammalian targets of Myc activation [6], and Pho and Pc
are involved in setting up and binding to H3K27 methyl-
ation, respectively, we used sequential chromatin immu-
noprecipitation to determine whether Myc activation
targets in the embryo exhibit both methylation marks.
Using chromatin from wild type embryos, obtained over
Ash1 works against Pc/Pho repression to facilitate Myc acti- vation Figure 7
Ash1 works against Pc/Pho repression to facilitate 
Myc activation. (A) Changes in expression of 77 genes are 
shown, log2 of ratios of expression over basal, for transcripts 
whose levels increase with ectopic Myc (blue bars). For each 
of the 77 genes, changes in expression are also shown in 
embryos with ectopic Myc and ash1 RNAi (red bars, next to 
the blue bar for each gene). (B) A graph showing the expres-
sion of 60 genes in response to eight genetic conditions, as 
clustered by K-means. The log10 scale of normalized expres-
sion for each gene is represented as a vertical line, and along 
the X axis left to right, the 60 are grouped by sample: Gal4 
alone, Gal4 Myc, Gal4 Pc RNAi, Gal4 Myc Pc RNAi, Gal4 ash1 
RNAi, Gal4 Myc ash1 RNAi, Gal4 pho RNAi, Gal4 Myc pho 
RNAi. These Myc activated genes fail to be activated with 
ash1 RNAi (compare 2nd and 6th sets), and they are also 
repressed by Pc and Pho (compare 1st, 3rd and 7th sets). (C) A 
Model suggesting a possible regulation scheme for the genes 
shown in B, "X".BMC Molecular Biology 2007, 8:40 http://www.biomedcentral.com/1471-2199/8/40
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Myc targets of activation are methylated at both H3K4 and H3K27 Figure 8
Myc targets of activation are methylated at both H3K4 and H3K27. (A) (Left) A graph showing basal levels of 680 
Myc activated targets (blue, left bar, each gene is represented by a thin line) followed by their levels upon ectopic Myc activa-
tion (blue, right bar, same genes as in the left bar). (Right) Basal levels of 57 Myc repression targets are shown (red, left bar, 
each gene is represented by a single thin line), and their levels following the activation of ectopic Myc (red, right bar, same 
genes as in the left bar). Compare basal levels of the activation targets versus repression targets. (B) Myc activation targets that 
are also regulated by Pc, Pho and Ash1 are methylated at both H3K4 and H3K27. DNA purified from chromatin immunopre-
cipitation reactions provided the template for PCR of CG16712 (upper) and CG18108 (lower), and the ChIP antibodies used 
are indicated above each lane. The right two lanes show results from sequential ChIP of chromatin by one antibody and then 
another. Input chromatin DNA is shown the far left lane, used in a 1:1000 dilution. (C) The enrichment by IP of chromatin con-
taining 6 genes was calculated by dividing the levels of PCR product by that of the background, no antibody control. CG16712, 
aTub67C and fs(1)N are all Myc induced, Pc, Ash1 and Pho repressed, and show methylation of H3K4 and K3K27 together. 
Atg8a is not affected by any of the four regulators, though it is highly expressed in the embryo and methylated at H3K4 (blue 
bar). Cyp309a1 and CG18108 are Myc/Pc repressed, and show both H3K4 and H3K27 methylation in wild type embryos, but 
not at the same locus by sequential ChIP. (D) A target of activation by Myc is depicted, with low levels of expression, in a 
domain of chromatin bearing H3K27 methylation and H3K4 methylation. A growth signal or other signal, including increased 
Myc accumulation, allows Myc/Max to bind to a binding site, recruiting activators and inducing transcription. Ash1 is shown 
directly or indirectly repelling PcG repression and maintaining an active H3K4 methylation state. (E) A target of Myc repression 
is depicted, with high levels of expression mediated by an unknown transcription factor (TF). A cellular signal and increased 
Myc accumulation allow Pho and Pc required repression, propagating a repressed chromatin state characterized by H3K27 
methylation.BMC Molecular Biology 2007, 8:40 http://www.biomedcentral.com/1471-2199/8/40
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a 24 hour room temperature collection, we immunopre-
cipitated with anti-dimethyl H3K4, purified the chroma-
tin, and immunoprecipitated again with anti-trimethyl
H3K27. We also performed the reciprocal experiment,
beginning with anti-trimethyl H3K27 and following with
anti-dimethyl H3K4 (See Methods, and [52]). We used
PCR to detect three different genes that are Myc activated,
Pc, Ash1 and Pho repressed (CG16712, fs(1)N, and alpha
Tubulin 67C, Figure 8B–C). All three of these genes were
amplified from our sequential ChIP DNA, arguing that
they are modified on both H3K4 and H3K27. As a control,
we examined a gene that is not regulated by Myc, Pc, Ash1
or Pho (Atg8a) and found it absent in our sequential ChIP
DNA, though it is expressed at high levels in the embryo
and methylated at H3K4 (Figure 8C). In addition, we
tested two genes that are Pc and Myc repressed (CyP309a1,
CG18108, respectively [18]), and they show both H3K4
and H3K27 methylation individually in chromatin from
wild type embryos. This result is not unexpected, since we
obtained the chromatin from all the cells of wild type
embryos, so that different cells may be expressing or
repressing each gene. We found that these loci are not
methylated at both residues simultaneously, because we
failed to amplify either gene from our sequential ChIP
DNA (Figure 8B–C). These results, along with our genetic
and genomic data, support a model for the control of Myc
targets in the embryo, in which Ash1, Pc and Pho are
required for the low levels of expression of these genes,
reflected by the disparate chromatin methylation of tar-
gets of Myc activation (Figure 8D). Developmentally reg-
ulated genes in mammalian embryonic stem cells also
exhibit low levels of expression prior to differentiation,
corresponding to methylation of both H3K4 and H3K27
[52].
Myc repression targets, different from activation targets,
are expressed in the embryo prior to ectopic Myc induc-
tion (Figure 8A). Bracken and colleagues have shown that
PcG proteins bind at expressed loci prior to differentiation
and repression, and those sites also have H3K27 methyla-
tion [22]. We have observed H3K27 methylation of Myc
targets in wild type embryos (Figure 8B–C), suggesting
that they are primed for repression, and upon ectopic Myc
induction Pho and Pc work to repress these targets. The
role of Ash1 in repression of these targets may be limited
to the embryo, possibly to allow for trans-activation in the
event of an activation signal, rather than a less reversible
Pc-mediated silenced state (Figure 8E).
Discussion
The requirement for Ash1 in activation and maintenance 
of non-activation
Our genetic assay for modification of expression of the
dmyc locus enabled us to identify an unexpected interac-
tion, namely that gene regulation by Ash1 in the embryo
overlaps gene regulation by Myc, Pc and Pho. We found
that a deletion of ash1 leads to greater expression of a
mini-white reporter within the dmyc locus, which poten-
tially reflects repression of dmyc in the eye imaginal disc.
In addition, ash1 RNAi in the embryo causes the induc-
tion of 239 genes. Interestingly, homeotic transforma-
tions in flies mutant for ash1 are enhanced by mutations
in Psc [53], a PcG gene that is part of the core repressive
complex including Pc [34]. Thus, the current understand-
ing of Ash1 as a nuclear protein involved in the complex
regulation of cellular memory does not exclude the possi-
bility that Ash1 may be involved in repression of certain
genes, directly or indirectly. Ash1 was identified as a late
larval lethal mutation with imaginal disc defects [54].
Expression of homeotic selector genes in ash1 mutants is
affected differently in different cells, with stochastic loss
of expression [48] apparently caused by ectopic silencing
by Pc-G proteins [47]. Flies heterozygous for a mutation
in ash1 show homeotic transformations when the fly is
also heterozygous for another trxG mutation [51]. This
intergenic non-complementation indicates that levels of
TrxG proteins are important, which is supported by the
large genomic effects we describe with just a 2-fold reduc-
tion in ash1 transcripts. The Ash1 protein is a SET domain
histone methyltransferase that methylates lysines 4 and 9
of histone H3 and lysine 20 of histone H4, and these com-
bined activities are correlated with active transcription
[45,46]. Interestingly, methylation of histone H3 lysine 9
is reduced in the chromocenter of polytene chromosomes
in ash1 mutants lacking the SET domain [46], and H3K9
methylation is associated with HP-1 binding and hetero-
chromatin formation [55-57]. In addition, Ash1 binds to
108 bands on polytene chromosomes, several of which
overlap or are adjacent to binding sites of Psc [50]. We
found that among the 239 genes that are up-regulated
with ash1 RNAi, 130 are also up-regulated with Pc RNAi,
139 are up-regulated with pho  RNAi, with 73 of these
genes common to all three. These results suggest that Ash1
methylation is not exclusive to transcriptional activation.
Ash1 also appears to be involved in activation of a differ-
ent set of embryonic targets, and many of the genes in this
set overlap Myc activation targets. In fact, we found that
ectopic Myc can replace Ash1 in embryos with both ash1
RNAi and ectopic Myc by activating 76% of the genes
whose expression decreases with ash1  RNAi alone. In
addition, we argue that Ash1 is required in Myc activation
of a subset of its targets, presumably by antagonizing Pc/
Pho repression. H3K4 methylation is correlated with Myc
binding to high affinity target sites, and this methylation
occurs in the absence of Myc protein, suggesting that it is
established and then Myc is able to bind [6]. Ash1 may
function to maintain a favorable methylation state of Myc
targets, allowing subsequent activation by Myc.
We found minimal direct overlap of Ash1 activation with
Pc and Pho repression. Our threshold values for determin-
ing genes affected by each genetic condition likely caused
false negative results; in addition, ash1 transcript levelsBMC Molecular Biology 2007, 8:40 http://www.biomedcentral.com/1471-2199/8/40
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were not depleted as effectively as Pc or pho levels. Our
experiments were conducted with RNA from entire
embryos, therefore we cannot determine the segment-spe-
cific regulation by the genes that we tested, and the over-
lap of Pc and Pho repression with Ash1 activation would
be expected to occur in a segment-specific manner. Fol-
lowing that argument, the large overlap of Ash1, Pc and
Pho repression targets may be related to universal genetic
programs, including Myc transcriptional activation, in
contrast to the cell-type specific programs, such as those
under the control of homeotic genes.
Pho's activity overlaps Myc targets better than Pc targets
We found many of the transcripts that are de-repressed by
pho RNAi overlap those that are de-repressed by Pc RNAi,
but more of the Pho targets overlap those that are Myc
activated than Pc repressed. Our stringent statistical
requirement for the membership of any transcript in a list
of genes that increase or decrease in response to a particu-
lar genetic condition may reduce our view of the overlap
of genes regulated by both Pc and Pho. But a difference in
the effects of loss of Pc and loss of Pho is not unprece-
dented. pho mutants have segmental transformations sim-
ilar to those of Pc mutants, however these mutations have
either little or no effect on expression of abd-A, abd-B or
Ubx in embryos [20,58-60]. And yet, Pho is required for
silencing of the iab-7 PRE [61] and is necessary, though
not sufficient, for the silencing activity of the MCP ele-
ment of the Abd-B gene [62]. Our data and the earlier
experiments we described may reveal the redundancy of
Pho and Pho-like, which is a homolog of Pho and binds
to the same sequence [28,63]. Wang and colleagues found
that Pho-like recruits PcG complexes just as Pho does in
the wing imaginal disc [32].
Conclusion
Our data have revealed that there is tremendous overlap
and plasticity of regulation by proteins whose functions
have been thought to be disparate. We are left with a view
of the embryonic genome in which the transcription fac-
tor Myc is capable of activation and repression of many
loci, and its canonical binding site is less important than
the influence of proteins whose role in biology is to main-
tain cell fates. The methylation status of chromatin sur-
rounding Myc targets supports the notion that the nucleus
of a wild type embryo is primed to control its response to
a transcription factor such as Myc.
Methods
Fly strains and crosses
See Flybase for additional information about the mutants
and insertions used. dmycBG02383,  dmycBG00605, and
BG00979 were generated by the Drosophila P-Screen/Gene
Disruption Project.
For the RT-PCR data shown in Figure 1, we crossed
females homozygous for dmycBG02383 on the X Chromo-
some and homozygous for a maternal tubulin Gal4 driver
on the Second and Third chromosomes (matTub-
Gal4VP16 67C;15) to males hemizygous for dmycBG02383
on the X Chromosome and homozygous for UAS-dmyc on
the Third chromosome [64]. For control embryos lacking
ectopic Myc, we crossed dmycBG02383 ; Gal4 driver females
to their siblings. For ectopic expression of dmyc used in the
microarray experiments, females homozygous for an
armadillo-Gal4  driver [65] were crossed to males
homozygous for UAS-dmyc [64]. Control embryos were
collected from mothers and fathers homozygous for arma-
dillo-Gal4.
For the mini-white assay for dmyc expression, we crossed
females homozygous for each insertion on the X Chromo-
some to males heterozygous for Pc,  Psc,  E(z)  and  pho
mutations and scored all the male progeny by their eye
color (all the male progeny of the cross will be
hemizygous for their mother's X chromosome,
dmycBG02383 or dmycBG00605, and heterozygous for either a
mutant chromosome or the balancer). We scored the
males within a few hours of eclosing and grouped them
based on intensity of mini-white expression. We counted
the flies in each of three groups (light, dark, neither), and
looked for differences in representation of males with the
mutation versus males with the balancer chromosome
(effectively wild type). We crossed dmycBG02383
homozygous females to males of the Bloomington stock
center's deficiency collection that includes deletions span-
ning 80% of the Second and Third Chromosomes (Figure
1C). We scored F1 males as described for Pc, Psc, E(z) and
pho mutations.
RNAi
We amplified 500 bp of 5' regions of the ash1 and pho
cDNAs, and cloned the products using the pGem T Easy
vector (Promega). We synthesized the sense and antisense
transcripts separately using the dual promoters of pGem T
Easy, SP6 and T7 polymerases (Ambion), and annealed
the transcripts to each other. We injected a 5 µM solution
of the dsRNA into dechorionated embryos, as previously
described [66]. Injected embryos were washed off the
cover slip with heptane to solubilize the glue and oil. We
removed the heptane and froze the embryos before
homogenization in TRIzol.
Injected embryos were all alive and undergoing germ
band retraction (approximately mid-embryogenesis)
before RNA isolation. None exhibited any mutant pheno-
type, including those with ectopic Myc, which is lethal by
the end of embryogenesis.BMC Molecular Biology 2007, 8:40 http://www.biomedcentral.com/1471-2199/8/40
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RNA isolation and RT-PCR
We used TRIzol reagent (Invitrogen) to isolate total RNA
from dechorionated embryos. RT-PCR reactions were per-
formed using Invitrogen's SuperScript One Step RT-PCR
system, as previously described [18]. Primer pairs for all
amplification products spanned an intron to control for
DNA contamination. We minimized amplification cycles
in order to remain in the linear range of amplification.
Microarray data treatment
We began our analysis of the data by eliminating genes
from our analysis whose levels were below a threshold.
We determined that threshold using signals for negative
controls on the arrays, such that genes whose levels were
less than 2.5 times the signal for a negative control were
not considered in our analysis. In the next step we nor-
malized the raw data by averaging the signals of several
Drosophila  positive controls (4 different actin signals),
comparing those averages across arrays (16 arrays, from
biological replication of 8 samples), and multiplying all
signals by a resulting chip-specific constant. We then aver-
aged signals for each gene in biological replicates. We
were left with data for eight experiments, normalized to
be comparable.
To compare changes in gene expression between genetic
conditions, we generated ratios of expression for each
genetic condition by dividing all signals by their corre-
sponding signal in the Gal4 no RNAi sample. As described
previously, we took the log2 for each ratio, found the
mean of the ratios for each of seven lists of ratios, deter-
mined the standard deviation from the mean, and classi-
fied genes as changing up or down based on the standard
deviation from the mean. Genes whose ratios were 1.5
times the standard deviation were classified as being
induced or de-repressed, and genes whose ratios were -1.5
times the standard deviation were classified as being
repressed or de-activated (in the cases of up with Pc- and
Myc activated, we used 2 times the standard deviation,
because levels for many more genes went up than down in
those samples). Following this classification, we estab-
lished lists for genes as follows: up with Myc, down with
Myc, up with ash1-, down with ash1-, up with pho-, down
with pho-, up with Pc-, down with Pc-, up with Myc ash1-,
down with Myc ash1-, up with Myc pho-, down with Myc
pho-, up with Myc Pc-, down with Myc Pc-. We generated
these lists using normalized data in Excel, and loaded the
raw data and our lists into GeneSpring for clustering and
figure generation. Our complete data set is available in
Additional file 1. Cel files and other file types containing
the data are available upon request.
Chromatin immunoprecipitation
We performed single ChIPs as described previously [18],
and sequential ChIPs as described by Bernstein and col-
leagues [52]. We used anti tri-methyl H3K27 (Upstate) at
a 1:100 dilution, and anti di-methyl H3K4 (Upstate) at a
1:100 dilution, and used primers to amplify the 5'-most
400 bp of each gene. For single ChIPs we used 30 ampli-
fication cylces, and for sequential ChIP we used 35 cycles.
Band intensities of PCR products were determined using
an Alpha Innotec device and Fluor-Chem software.
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